Target intelligence / Profile preview

Dissipate stasis and accumulation

01

Overview

Dissipate stasis and accumulation (often referred to as 'San Jie Hua Yu' or 'Xiao Ji') is a therapeutic principle in Traditional Chinese Medicine (TCM) rather than a specific molecular target such as a receptor or enzyme. It describes a pharmacological strategy aimed at resolving blood stasis, improving microcirculation, and breaking down physical accumulations or masses in the body, which in modern medicine often correspond to tumors, cysts, or fibrotic tissue (World Health Organization International Standard Terminologies on TCM, 2022). In a clinical context, this principle is applied to treat conditions characterized by chronic inflammation, abnormal tissue proliferation, and circulatory obstructions. Modern scientific research indicates that the herbs and formulas associated with this action exert their effects through a multi-target approach, including the inhibition of platelet aggregation, modulation of the coagulation cascade, and the induction of apoptosis in tumor cells (PubMed, 2020). Because it represents a broad category of therapeutic action rather than a discrete biological entity, it does not possess a canonical molecular structure or a single gene association.

Other names
Resolving blood stasis and dissipating massesXiao Ji Hua YuSan Jie Hua YuRemoving blood stasisDissipating phlegm and resolving massesHuo Xue Hua Yu
02

Mechanism of action

This term refers to a Traditional Chinese Medicine (TCM) therapeutic strategy rather than a single molecular mechanism; it involves the use of multi-component herbal formulas to modulate blood rheology, inhibit pro-inflammatory cytokines, and downregulate pro-fibrotic pathways such as TGF-beta/Smad signaling to resolve pathological 'stasis' and tissue masses (National Center for Biotechnology Information, 2021).

03

Biological functions

Regulation of blood circulationFibrinolysisAnti-inflammatory responseApoptosis inductionInhibition of platelet aggregation
04

Disease associations

CancerCardiovascular diseaseEndometriosisUterine fibroidsLiver cirrhosisThrombosis
05

Safety considerations

Increased risk of hemorrhagePotential interactions with pharmaceutical anticoagulants like WarfarinContraindicated during pregnancy due to abortifacient potentialGastrointestinal irritation
06

Interacting drugs

Xuefu Zhuyu Tang

5 more in the full profile.

07

Biomarkers

D-dimerFibrinogen degradation productsPlatelet aggregation rateWhole blood viscosity

Beyond the preview

Go deeper on Dissipate stasis and accumulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dissipate stasis and accumulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call